These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7483342)

  • 1. [Angiotensin converting enzyme inhibitors in the treatment of arterial hypertension].
    Widimský J
    Vnitr Lek; 1995 Aug; 41(8):560-4. PubMed ID: 7483342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical aspects of use of angiotensin-converting enzyme inhibitors in patients with arterial hypertension].
    Widimský J
    Cas Lek Cesk; 1998 Mar; 137(6):175-8. PubMed ID: 9588103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical aspects of use of beta-blockers in the treatment of arterial hypertension].
    Widimský J
    Vnitr Lek; 1997 Apr; 43(4):221-5. PubMed ID: 9601840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
    Brilla CG; Rupp H; Maisch B
    Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
    Bramlage P
    Expert Opin Pharmacother; 2009 Aug; 10(11):1755-67. PubMed ID: 19538001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors after renal transplantation.
    Bravo P; Felgueiras J; Santos C; Oliveira C; Ponce P
    Transplant Proc; 2008 Apr; 40(3):740-2. PubMed ID: 18455003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Angiotensin converting enzyme inhibitors for hypertension].
    Kobusiak-Prokopowicz M
    Pol Merkur Lekarski; 1997 Jan; 2(7):66-70. PubMed ID: 9296907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renin-angiotensin-aldosterone system inhibition: pharmacologic rationale and evaluations of drug combinations].
    Andréjak M; Slama M; Hary L
    Therapie; 1998; 53(3):291-300. PubMed ID: 9773129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
    Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Captopril and other angiotensin converting enzyme inhibitors in the treatment of hypertension].
    Hradec J
    Vnitr Lek; 1995 May; 41(5):336-9. PubMed ID: 7653065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rationale for the use of renin-angiotensin inhibitors in the treatment of arterial hypertension and correlated organ damage].
    Mammarella A; Paoletti V; De Matteis A; Di Franco M; Cavina G; Paradiso M
    Clin Ter; 2002; 153(1):45-9. PubMed ID: 11963634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late onset angiotensin-converting enzyme induced angioedema: case report and review of the literature.
    Guo X; Dick L
    J Okla State Med Assoc; 1999 Feb; 92(2):71-3. PubMed ID: 10024785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone further reduces urinary albumin excretion and plasma B-type natriuretic peptide levels in hypertensive type II diabetes treated with angiotensin-converting enzyme inhibitor.
    Ogawa S; Takeuchi K; Mori T; Nako K; Ito S
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):477-9. PubMed ID: 16700881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE inhibitor-based treatment and antihypertensive effects in patients with type 2 diabetes.
    Jarmuzewska EA; Rocchi R; Guidoni A; Mangoni AA
    Panminerva Med; 2008 Sep; 50(3):207-16. PubMed ID: 18927524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications.
    Kolasinska-Malkowska K; Filipiak KJ; Gwizdala A; Tykarski A
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):759-71. PubMed ID: 18510491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A prospective study on the cough mechanism induced by angiotensin-converting enzyme inhibitors in patients with hypertension].
    Ye RJ; He QY; Gai J; Shang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):581-4. PubMed ID: 15498266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noscapine suppresses angiotensin converting enzyme inhibitors-induced cough.
    Mooraki A; Jenabi A; Jabbari M; Zolfaghari MI; Javanmardi SZ; Mahmoudian M; Bastani B
    Nephrology (Carlton); 2005 Aug; 10(4):348-50. PubMed ID: 16109080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors in the therapy of renal diseases.
    Lefebvre HP; Toutain PL
    J Vet Pharmacol Ther; 2004 Oct; 27(5):265-81. PubMed ID: 15500563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiotensin converting enzyme inhibitors in arterial hypertension].
    Ramón González-Juanatey J
    Rev Esp Cardiol; 1999; 52 Suppl 3():73-8. PubMed ID: 10614152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of angiotensin receptor antagonists and angiotensin converting enzyme inhibitors in arterial hypertension].
    Krezsinski JM; Sternon J
    Rev Med Brux; 2000 Jun; 21(3):170-7. PubMed ID: 10925600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.